Animal testing for all non-essential cosmetic products should be banned worldwide.

This was a closely contested debate in which both sides demonstrated competence but also significant weaknesses. The debate centered on three core battlegrounds: the scientific readiness of alternative testing methods, the real-world track record of existing bans (particularly the EU's), and the equity implications for developing nations.

Pro built their case around the EU's 13-year track record without documented consumer harm, the growing scientific validation of alternatives (citing organ-on-chip technology, in vitro methods, and computational modeling), and the ethical imperative against causing animal suffering for non-essential products. Their strongest rhetorical move was repeatedly challenging Con to produce a single documented case of consumer harm under the EU ban—a challenge Con never directly met. However, Pro was vulnerable on the "grandfathering problem" (the EU ban's reliance on safety data originally derived from animal testing), and they never adequately addressed this point despite it being raised multiple times.

Con argued that alternatives cannot yet replicate complex systemic biological responses (repeated dose toxicity, reproductive toxicity, sensitization pathways), that the EU ban's success is misleading because it grandfathers in decades of animal-tested safety data, and that a worldwide ban would disproportionately burden developing nations lacking regulatory infrastructure. Con's grandfathering argument was genuinely incisive and represented the debate's most significant unanswered challenge. However, Con struggled with their own logical tension: they acknowledged animal testing's limitations while simultaneously arguing it remains indispensable, and they never produced concrete evidence of harm from existing bans.

The debate's turning point came in Round 3, where the grandfathering problem became central. Pro's failure to substantively engage with this argument was their most significant weakness. Conversely, Con's inability to cite any real-world safety failures from existing bans undermined their consumer safety warnings.

Both sides relied heavily on assertion over citation. Neither provided specific study names, journal references, or data points with sufficient rigor. Both engaged in some degree of cherry-picking and rhetorical inflation.